Business Potential for Agricultural Biotechnology - Asian Productivity ...
Business Potential for Agricultural Biotechnology - Asian Productivity ...
Business Potential for Agricultural Biotechnology - Asian Productivity ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
– 7 –<br />
Summary of Findings<br />
field trials from 1996 to 1999, the transgenic papaya exhibited high degrees of protection against<br />
PRSV in the Republic of China. Un<strong>for</strong>tunately, 18 months after planting in the fourth field trial,<br />
unexpected symptoms of severe distortion on fully expanded leaves, stunning on apex, watersoaking<br />
on petioles and stem, and yellow ringspot on fruit were noticed on PRSV CP-transgenic<br />
papaya plants. The causal agent was distinguished from PRSV by host reactions and serological<br />
properties and later identified as Papaya leaf distortion mosaic virus (PLDMV), a potyvirus<br />
which originated from Okinawa, Japan, in 1954. All PRSV CP-transgenic papaya lines were susceptible<br />
to PLDMV infection when evaluated under greenhouse conditions. There<strong>for</strong>e, in the Republic<br />
of China PLDMV will be considered a serious threat to papaya production once PRSV<br />
CP-transgenic papaya is widely used <strong>for</strong> the control of PRSV.<br />
In order to control two or more viruses, transgenic plants with multiple resistances have<br />
been generated by combining the entire CP gene of more than one virus, with each gene driven<br />
by a promoter and a terminator. Transgenic lines expressing these chimeric CP constructs were<br />
resistant to the corresponding viruses and protected from mixed infection such as Cucumber<br />
mosaic virus, Watermelon mosaic virus, and Zucchini yellow mosaic virus. Furthermore, transgenic<br />
plants with resistance to a potyvirus and a tospovirus can be obtained through the PTGS<br />
mechanism by fusing a segment of tospoviral N gene to a segment of potyviral CP gene. This<br />
strategy was used to develop double resistance to both PRSV and PLDMV. An untranslatable<br />
chimeric construct that contained the truncated PRSV CP and PLDMV CP genes was then transferred<br />
to papaya. Through the PTGS mechanism, transgenic papaya plants carrying this chimeric<br />
transgene indeed conferred resistance against both PRSV and PLDMV under greenhouse conditions.<br />
These transgenic papaya plants with double resistance are considered to have great potential<br />
<strong>for</strong> the control of PRSV and PLDMV in Taiwan. In four-year field trials, a super PRSV<br />
strain 5-19 which infected transgenic papaya lines was found. The breakdown of the transgenic<br />
resistance by a strong gene-silencing suppressor of a super strain has a strong impact on the application<br />
of transgenic crops <strong>for</strong> virus control. A chimeric construct targeting at multiple viral<br />
genes, including the gene determining viral virulence and gene silencing suppression, such as the<br />
HC-Pro gene of a potyvirus, may minimize the chance of emergence of a super virus <strong>for</strong> overcoming<br />
the transgenic resistance.<br />
Commercial-scale Production of Valuable Plant Biomass and Secondary Metabolites Using<br />
a Bioreactor System<br />
Plants are a de facto biological factory that produces an immense array of fine chemical<br />
compounds highly valued in pharmaceutical, food, and bioenergy industries. Thus it is of huge<br />
business interest to grow plant cells, tissues, and even entire organisms at commercial scales.<br />
Having proven its medicinal superiority in traditional medicine, Korean Mountain Ginseng<br />
(KMG) has a high market value among Korean people that has stimulated much interest in<br />
producing its biomass <strong>for</strong> commercialization. However, there have been only a few success<br />
stories of plant cultures at the commercial scale. Recently, a group at VitroSys Inc. successfully<br />
implemented an industrial-scale bioreactor system <strong>for</strong> the commercial production of Korean<br />
Mountain Ginseng (Panax ginseng C. A. Meyer). The bioreactor system holds a promising<br />
future <strong>for</strong> applications, such as the large-scale production of diverse secondary metabolites from<br />
plant tissues.<br />
Commercialization of <strong>Agricultural</strong> Crop <strong>Biotechnology</strong> Products<br />
High-quality seed of crop cultivars with the desirable genetic background still <strong>for</strong>m the<br />
foundation <strong>for</strong> farming. <strong>Biotechnology</strong> offers the best opportunity to meet the challenge of improving<br />
on the potential in seeds and also of providing the enabling knowledge to express that<br />
potential. Crops developed through biotechnology are produced by the stable insertion of one or<br />
a few well-defined genes into the genome of a plant. The gene(s) produce one or a few proteins<br />
that confer the trait of interest (e.g., insect resistance). Of the thousands of individual plants that